Sugi Predict

Sugi Predict / Compounds / SCHEMBL12430356

SCHEMBL12430356

SCHEMBL12430356

CC(C)(C)c1cc(-c2ccc(Oc3ccccc3)cc2)c(C#N)c(OS(=O)(=O)C(F)(F)F)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SQOR Q9Y6N5 6/20 0.52
▸ ALDH1A1 P00352 7/20 0.43
▸ KMT2A Q03164 7/20 0.43
▸ HPGD P15428 4/20 0.43
▸ KDM4E B2RXH2 4/20 0.43
▸ NPSR1 Q6W5P4 4/20 0.43
▸ GAA P10253 2/20 0.43
▸ PAX8 Q06710 1/20 0.43
▸ MEN1 O00255 3/20 0.40
▸ GRM2 Q14416 2/20 0.40
▸ CYP1A2 P05177 3/20 0.39
▸ CYP2C19 P33261 3/20 0.39
▸ LMNA P02545 3/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ MAPT P10636 2/20 0.39
▸ MITF O75030 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12430358 0.87 PIM1 (0.48) SQORALDH1A1KMT2AHPGDKDM4E
SCHEMBL2816528 0.86 SQOR (0.55) SQORALDH1A1KMT2AHPGDKDM4E
SCHEMBL2206150 0.85 ALDH1A1 (0.47) SQORALDH1A1KMT2AHPGDKDM4E
SCHEMBL12430361 0.84 SQOR (0.51) SQORALDH1A1KMT2AHPGDKDM4E
SCHEMBL14340812 0.84 SQOR (0.53) SQORALDH1A1KMT2AHPGDKDM4E
SCHEMBL2819227 0.84 SQOR (0.48) SQORALDH1A1KMT2AHPGDMEN1
SCHEMBL12430538 0.84 DRD2 (0.39) SQORALDH1A1KMT2AHPGDKDM4E
SCHEMBL2820135 0.83 MEN1 (0.52) SQORALDH1A1KMT2AHPGDMEN1
SCHEMBL12430547 0.83 GRM2 (0.39) SQORALDH1A1KMT2AHPGDKDM4E
SCHEMBL2816429 0.82 SQOR (0.51) SQORALDH1A1KMT2AHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977325-B2 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents BAYER SCHERING PHARMA AG (DE) 2011-07-12 — — US disclosed
US-7977325-B2 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents BAYER SCHERING PHARMA AG (DE) 2011-07-12 — — US disclosed
US-20090030010-A1 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents GENESYS CLOUD SERVICES, INC. 2009-01-29 — — US disclosed
US-20090030010-A1 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents GENESYS CLOUD SERVICES, INC. 2009-01-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030010-A1 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents MAP4K2, ABL1, MAP4K3 SQOR 1563/4885ALDH1A1 2786/4885KMT2A 1372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.